You are here

  • Home
  • Archive
  • Volume 76, Issue 6
  • Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting

Article metrics

Article menu
Original research
Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting
Free

 

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

AbstractFullPdf
Jan 2022677676120
Feb 202230029649
Mar 202212912449
Apr 2022938822
May 2022898633
Jun 202280777
Jul 2022706911
Aug 2022666518
Sep 2022696620
Oct 2022646213
Nov 2022726619
Dec 202254516
Jan 20231411389
Feb 2023898611
Mar 2023745017
Apr 202312011
May 202330615032
Jun 202316915736
Jul 2023989330
Aug 2023878714
Sep 2023838618
Oct 202389869
Nov 2023866319
Dec 20231129025
Jan 2024726918
Feb 202458509
Mar 202416615527
Total35133087642